CClinicalTrials.gg
Enrolling by invitationNCT07273565Updated Jun 25, 2026

Feasibility of Comparing Microwave Images to Clinical Information in Patients Recalled for Follow-up Breast Imaging

An interventional study of WVI-MIS-02-2025 in Breast - Female, sponsored by University of Calgary. Enrolling by invitation at 1 site in Canada. Open to female participants aged 18 Years to 74 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by University of Calgary · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years to 74 Years
Sex
Female
01

Study summary

The goal of this clinical trial is to measure the electrical properties of breast tissues using microwave technology and to compare these collected measurements to clinical information in mammograms and/or breast ultrasound for women that have been recalled for follow-up breast imaging or further investigation. The main questions it aims to answer are:

  1. Can the breast area and plate separation in the microwave scan be compared to mammogram data (where available) to assess similarity in breast positioning and the feasibility of image registration?
  2. Can the distribution of electrical properties specifically glandular tissue distribution in the microwave image be compared to that observed in the mammogram (where available)?
  3. Can the characteristics of the microwave image in the localized region corresponding to an identified anomaly in the breast imaging data be examined?

Study participants will be scanned with the Wave View microwave scanner on the same day as their follow-up breast imaging appointment. Each breast will be scanned up to 3 times with the scanner oriented in both the horizontal position and oriented at 45 degrees. Study participants will also be asked to fill out three surveys, one relating to breast health and the other two relating to their scanning experience.

Read the detailed description

A new approach to imaging that uses low-power microwaves to scan the breast has been developed. Since the imaging system uses low power, there is no risk of tissue heating. The imaging system places the sensors in contact with the breast tissue. The research team at the University of Calgary has previously developed microwave imaging systems that have been tested on healthy volunteers and breast cancer patients. A group of healthy volunteers were repeatedly scanned to evaluate the consistency of the imaging approach. Another study involved scanning breast cancer patients before each round of neoadjuvant chemotherapy. The information collected from experiences scanning volunteers and patients have been reviewed and translated into a next-generation imaging system design. Aspects of this system have been further improved by Wave View Imaging, which is a company formed by members of the University's research team.

The proposed study involves collecting electrical property measurements of breast tissues and comparing these measurements to clinical information in mammograms and/or breast ultrasounds. The investigators also aim to compare regions of interest in the microwave scans with regions of interest in the mammograms (where available). This includes regions dominated by fibroglandular tissues, as well as regions of interest that correspond to anomalies identified in the mammograms and/or breast ultrasounds.

The plan is to scan both breasts of up to 100 volunteers that have been recalled for follow-up breast imaging or further investigation. Each volunteer will participate in a single scanning session during their follow-up appointment. Breast tissue composition will be compared with the microwave properties and registration of mammograms (where available) with microwave images will be performed for a more detailed comparison.

02

Conditions studied

  • Breast - Female

Keywords

  • women
  • mammography
  • recall
  • breast
  • breast ultrasound
03

In context

Lead sponsor

University of Calgary is the lead sponsor of 686 studies on the registry; 189 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 74 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female sex
  • 18-74 years of age
  • Able to provide informed consent
  • Had a screening or diagnostic mammogram or breast ultrasound within the previous 6 weeks
  • Recalled for additional breast imaging due to BIRADS 3 or 4 or 5 findings.

Exclusion criteria

Exclusion Criteria:

  • Participants who have not received a mammogram or breast ultrasound
  • Participants who are currently undergoing breast cancer treatment or have had treatment in the past 6 months
  • Participants with breast implants
  • Participants who are pregnant or breastfeeding
  • Participants with active breast skin infections
  • Participants with nipple piercings (unless they are removed prior to scanning)
  • Participants with an implanted electronic device
  • Participants with physical limitations that prevent them from placing their breasts inside the Wave View scanner.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    WVI-MIS-02-2025

    A single arm study in which the collected microwave data is compared against available clinical data.

    Device: WVI-MIS-02-2025

Interventions

  • DeviceWVI-MIS-02-2025

    Microwave scans

06

What researchers measure

Primary outcomes

  1. Measurement of electrical properties of breast tissues in microwave images

    The average electrical properties of the Wave View image will be calculated (relative permittivity and attenuation). The average properties of the right and left breasts will be compared. The average properties of the craniocaudal (CC) and mediolateral oblique (MLO) views will also be compared for both breasts.

    Time frame: 12 months

Secondary outcomes

  1. Examine the similarity in plate separation between mammography and Wave View scans

    The separation between the plates contacting the breast will be compared between the two modalities. This comparison provides an initial indication of the volume of breast tissue in the scanner.

    Time frame: 12 months

  2. Breast area

    The breast area on the mammogram will be compared to the breast area on the Wave View scan. The breast area in the Wave View image will be calculated, while the breast area on the mammogram is available from automated image analysis reports.

    Time frame: 12 months

  3. Examine the similarity between glandular tissue distribution on mammograms and electrical property images obtained with the Wave View scanner.

    The microwave image will be overlayed on the mammogram to provide initial insight on glandular tissue distribution via visual inspection. The images will be registered based on the outline of the breast. If the breast areas are found to differ, deformable registration techniques will be applied. Higher intensity regions representing glandular tissues will be identified in both images via image filtering and segmentation. These regions will be compared with metrics such as the Dice coefficient. In addition, the area of the higher intensity region will be compared with the overall area of the breast image, similar to the method used to calculate the percentages used in breast density analysis.

    Time frame: 12 months

  4. Examine how closely the presence of responses in Wave View scans correspond to anomalies detected on mammograms and/or breast ultrasounds

    Localized regions in the Wave View image that correspond to locations of anomalies on the mammogram or breast ultrasounds will be identified based on the registered images. The average properties of these regions will be compared with the average properties of a region in the same breast, as well as in the contralateral breast.

    Time frame: 12 months

  5. Estimate of breast composition

    Pureform Radiology uses a breast density tool to automatically calculate the volume of the breast and glandular tissue, as well as the percentage density and density category (A, B, C, D). Microwave properties are expected to be greater with greater breast densities.To compare electrical properties to breast density, average electrical properties of each microwave scan will be plotted against the corresponding percent density.

    Time frame: 12 months

07

Study locations

1 site
  • Pureform Radiology
    Calgary, Canada
08

References and documents

Publications

  • C. M. Butterworth, P. Mojabi, and E. C. Fear, "Quantifying Consistency of Microwave Breast Imaging: Laser Scanning for Assessing Breast Volume and Shape," IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology, pp. 1-9, 2025, doi: 10.1109/JERM.2025.3531693
  • Mojabi P, Bourqui J, Lasemiimeni Z, Grewal B, Fear E. Microwave Imaging for Breast Cancer Detection: Performance Assessment of a Next-Generation Transmission System. IEEE Trans Biomed Eng. 2025 Jun;72(6):1787-1799. doi: 10.1109/TBME.2024.3521410. PubMed 40031671 ↗
  • Wang Z, Mojabi P, Price S, Lasemiimeni Z, Besler B, Bourqui J, Deutscher D, Besler B, Shen H, Docktor B, Tsang RY, Fear E. Reproducibility of Microwave Breast Imaging: Analysis of Regular Scans of a Group of Volunteers. IEEE Trans Biomed Eng. 2025 May;72(5):1562-1571. doi: 10.1109/TBME.2024.3512572. Epub 2025 Apr 22. PubMed 40030750 ↗
  • Mojabi P, Bourqui J, Fear E. Fast 3D Breast Imaging With a Transmission-Based Microwave System. IEEE Trans Med Imaging. 2025 May;44(5):2206-2217. doi: 10.1109/TMI.2025.3527916. Epub 2025 May 2. PubMed 40030952 ↗
  • Smith K, Bourqui J, Wang Z, Besler B, Lesiuk M, Roumeliotis M, Quirk S, Grendarova P, Pinilla J, Price S, Docktor B, Fear E. Microwave imaging for monitoring breast cancer treatment: A pilot study. Med Phys. 2023 Nov;50(11):7118-7129. doi: 10.1002/mp.16756. Epub 2023 Oct 6. PubMed 37800880 ↗
  • Smith, K., et al. "Microwave Imaging of the Breast: Consistency of Measurements Over Time." IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology, vol. 6, no. 1, 2022, pp. 61-67, https://doi.org/10.1109/JERM.2021.3099014. . : . .

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07273565
Lead sponsor
University of Calgary
Collaborators
Pureform Radiology, Wave View Imaging Inc.
Responsible party
Sponsor
First posted
Dec 9, 2025
Start date
Mar 19, 2026
Primary completion
Oct 30, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
Jun 25, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion